Health Decisions, Inc.
Health Decisions, Inc. received $3.3M in federal prime contract obligations in the 12 months ending Oct 5, 2026, up 6.8% from $3.1M the year before, and $27.1M since FY2022. Its largest customer is the Department of Health and Human Services.
See 5 contracts ending in the next 18 months ↓Contractor details
- Unique Entity ID (UEI)
- CMKQYLSLNJG1
- CAGE code
- 3FAM0
- Headquarters
- Durham, NC
- Business size
- Small Business
As recorded on this UEI's most recent prime contract action in USAspending.gov. Confirm current registration and certifications in SAM.gov.
Obligations by fiscal year
Net prime contract obligations by federal fiscal year.
Top agencies
Funding agencies ranked by obligations since FY2022.
| Funding agency | Latest 12 mo | Since FY2022 |
|---|---|---|
| Department of Health and Human Services | $3.3M | $27.1M |
Top NAICS codes
Industry codes agencies recorded on this contractor's awards, since FY2022.
What it sells
Product and service codes (PSC) on this contractor's awards, since FY2022.
| PSC | Description | Since FY2022 |
|---|---|---|
| AN12 | Health R&D services; Health Care services; Applied Research | $27.1M |
Contracts ending in the next 18 months
This contractor's largest awards whose current period of performance ends soon. Options and extensions often move these dates.
| Award | Agency | Obligated | Current end |
|---|---|---|---|
| 75N94023F00003 | Department of Health and Human Services FINALIZATION, PROCUREMENT OF REGULATORY APPROVAL, AND COMPLETE START-UP ACTIVITIES FOR THE OVAPRENE VAGINAL DEVICE CLINICAL TRIAL | $2.2M | Jul 31, 2027 |
| 75N94026F00001 | Department of Health and Human Services NICHD:R&D:CCTN STATISTICAL AND CLINICAL COORDINATING CENTER (SCCC) CORE FUNCTION ACTIVITIES:SEVERABLE | $495K | Sep 19, 2027 |
| 75N94024F00001 | Department of Health and Human Services PROTOCOL FINALIZATION, START-UP, COORDINATION, MONITORING, AND ALL OTHER ASSOCIATED ACTIVITIES FOR CLINICAL TRIALS EVALUATING PROGESTOGENIC ANDROGENS AS CONTRACEPTIVE AGENTS | $994K | Sep 24, 2027 |
| 75N94025F00001 | Department of Health and Human Services NICHD: R&D: COORDINATION, MONITORING, FOLLOW-UP, EVALUATION, AND COMPLETION OF A CLINICAL TRIAL OF NESTORONE TESTOSTERONE GEL FOR MALE CONTRACEPTION: NON-SEVERABLE | $1.2M | Oct 31, 2027 |
| 75N94025F00002 | Department of Health and Human Services NICHD: R&D: SUPPORTING THE PHASE IIB CLINICAL TRIAL OF SUBCUTANEOUS LEVONORGESTREL BUTANOATE (LB) FOR FEMALE CONTRACEPTION: NON-SEVERABLE | $1.3M | Mar 31, 2028 |
Recent awards
This contractor's newest prime contract awards, most recent first.
| Award | Agency | Obligated | Awarded |
|---|---|---|---|
| 75N94026F00001 | Department of Health and Human Services NICHD:R&D:CCTN STATISTICAL AND CLINICAL COORDINATING CENTER (SCCC) CORE FUNCTION ACTIVITIES:SEVERABLE | $495K | Sep 18, 2026 |
| 75N94025F00002 | Department of Health and Human Services NICHD: R&D: SUPPORTING THE PHASE IIB CLINICAL TRIAL OF SUBCUTANEOUS LEVONORGESTREL BUTANOATE (LB) FOR FEMALE CONTRACEPTION: NON-SEVERABLE | $233K | Jul 25, 2025 |
| 75N94025F00001 | Department of Health and Human Services NICHD: R&D: COORDINATION, MONITORING, FOLLOW-UP, EVALUATION, AND COMPLETION OF A CLINICAL TRIAL OF NESTORONE TESTOSTERONE GEL FOR MALE CONTRACEPTION: NON-SEVERABLE | $700K | Apr 30, 2025 |
| 75N94024F00002 | Department of Health and Human Services ACQUISITION OF THE NESTORONE ESTRADIOL (NES/E2) VAGINAL RING | $1.2M | Sep 24, 2024 |
| 75N94024F00001 | Department of Health and Human Services PROTOCOL FINALIZATION, START-UP, COORDINATION, MONITORING, AND ALL OTHER ASSOCIATED ACTIVITIES FOR CLINICAL TRIALS EVALUATING PROGESTOGENIC ANDROGENS AS CONTRACEPTIVE AGENTS | $994K | Sep 19, 2024 |
| 75N94023F00003 | Department of Health and Human Services FINALIZATION, PROCUREMENT OF REGULATORY APPROVAL, AND COMPLETE START-UP ACTIVITIES FOR THE OVAPRENE VAGINAL DEVICE CLINICAL TRIAL | $1.5M | Aug 25, 2023 |
| 75N94023F00002 | Department of Health and Human Services STATISTICAL AND CLINICAL COORDINATING SERVICES FOR GROUPS C AND D OF CCN021 ENTITLED, "A STUDY TO EVALUATE THE PK AND PD OF IM OR SQ INJECTIONS OF LEVONORGESTREL BUTANOATE (LB)… | $347K | May 24, 2023 |
| 75N94023F00001 | Department of Health and Human Services COORDINATION, MONITORING, FOLLOW-UP, AND EVALUATION OF A CLINICAL TRIAL OF NESTORONE TESTOSTERONE GEL FOR MALE CONTRACEPTION | $2.1M | Dec 23, 2022 |
Prime contracts (award types A–D) from USAspending.gov through Oct 5, 2026. Subcontracts are not included. Net obligations include deobligations and corrections.
Ready to connect your pursuit work?
GovEagle gives BD directors, capture managers, and proposal teams one AI workspace from pipeline through proposal, with CMMC/FedRAMP Certified compliance built in.